WVE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 29.10%

Insider Buying (Last 12 Months): $22,335,440.00

Insider Selling (Last 12 Months): $8,522,029.83

Wave Life Sciences Insider Trading History Chart

Wave Life Sciences Share Price & Price History

^$8.08

▼ -0.54 (-6.26%)

As of 03/31/2025 05:00 PM ET

Days: 30 | 90 | 365

Wave Life Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/20/2025	Christian O. Henry	Director	Sell	10,500	$9.77	$102,585.00	16,115
3/7/2025	Paul Bolno	CEO	Sell	169,025	$9.57	$1,617,569.25	338,351
11/25/2024	Paul Bolno	CEO	Sell	50,000	$15.00	$750,000.00	217,351
11/15/2024	Paul Bolno	CEO	Sell	51,234	$14.32	$733,670.88	217,351
11/8/2024	Chris Francis	insider	Sell	36,000	$16.00	$576,000.00
10/16/2024	Chris Francis	insider	Sell	208,836	$13.67	$2,854,788.12
10/16/2024	Paul Bolno	CEO	Sell	90,474	$15.00	$1,357,110.00	268,585
9/27/2024	Plc Gsk	Major Shareholder	Buy	2,791,930	$8.00	$22,335,440.00	16,775,691
9/25/2024	Kyle Moran	CFO	Sell	17,146	$9.00	$154,314.00	19,777
8/21/2024	Paul Bolno	CEO	Sell	48,366	$5.78	$279,555.48	359,059
4/3/2024	Kyle Moran	CFO	Sell	15,630	$6.17	$96,437.10	33,921
12/11/2023	Ra Capital Management, L.P.	Director	Buy	1,000,000	$5.00	$5,000,000.00	19,202,009
8/23/2023	Kyle Moran	CFO	Sell	37,062	$4.75	$176,044.50	46,120
2/16/2023	Chandra Vargeese	Insider	Sell	10,249	$4.03	$41,303.47	106,624
2/16/2023	Kyle Moran	CFO	Sell	9,729	$4.04	$39,305.16	79,751
2/16/2023	Paul Bolno	CEO	Sell	29,400	$4.04	$118,776.00	407,425
6/16/2022	Ra Capital Management, L.P.	Director	Buy	9,480,052	$2.15	$20,382,111.80	17,202,009
5/5/2022	Chandra Vargeese	Insider	Sell	16,714	$1.72	$28,748.08	111,095
5/5/2022	Kyle Moran	CFO	Sell	5,021	$1.72	$8,636.12	84,567
5/5/2022	Paul Bolno	CEO	Sell	33,501	$1.72	$57,621.72	436,825

See Full Table

SEC Filings (Institutional Ownership Changes) for Wave Life Sciences (NASDAQ:WVE)

89.73% of Wave Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Wave Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	311,303	$3.85M	0.0%	-1.3%	0.203%
3/18/2025	California State Teachers Retirement System	98,237	$1.22M	0.0%	+30.9%	0.064%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	362,291	$4.48M	0.0%	N/A	0.238%
2/25/2025	Polar Asset Management Partners Inc.	557,323	$6.89M	0.1%	+14.7%	0.365%
2/19/2025	GF Fund Management CO. LTD.	3,202	$40K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	165,238	$2.04M	0.0%	+14.2%	0.108%
2/17/2025	Voloridge Investment Management LLC	845,830	$10.46M	0.0%	N/A	0.555%
2/17/2025	Velan Capital Investment Management LP	13,000	$0.16M	0.1%	N/A	0.009%
2/17/2025	Squarepoint Ops LLC	20,659	$0.26M	0.0%	N/A	0.014%
2/17/2025	Two Sigma Advisers LP	68,100	$0.84M	0.0%	N/A	0.045%
2/17/2025	Two Sigma Investments LP	391,620	$4.84M	0.0%	+210.4%	0.257%
2/17/2025	Stempoint Capital LP	721,209	$8.92M	2.2%	+140.4%	0.473%
2/17/2025	Rafferty Asset Management LLC	12,466	$0.15M	0.0%	N/A	0.008%
2/17/2025	Polar Asset Management Partners Inc.	557,323	$6.89M	0.1%	+14.7%	0.365%
2/17/2025	Polar Capital Holdings Plc	1,000,000	$12.37M	0.1%	N/A	0.656%
2/17/2025	ProShare Advisors LLC	33,184	$0.41M	0.0%	-24.6%	0.022%
2/17/2025	MPM Bioimpact LLC	1,489,237	$18.42M	2.6%	+138.5%	0.976%
2/17/2025	Nomura Holdings Inc.	15,017	$0.19M	0.0%	-24.9%	0.010%
2/17/2025	Nuveen Asset Management LLC	553,439	$6.85M	0.0%	+32.9%	0.363%
2/17/2025	Occudo Quantitative Strategies LP	19,936	$0.25M	0.0%	N/A	0.013%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	39,767	$0.49M	0.0%	-20.5%	0.026%
2/17/2025	Maven Securities LTD	170,000	$2.10M	0.1%	-80.0%	0.111%
2/17/2025	Millennium Management LLC	1,180,838	$14.61M	0.0%	+38.7%	0.774%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	52,392	$0.65M	0.0%	+23.3%	0.034%
2/17/2025	Deutsche Bank AG	70,466	$0.87M	0.0%	+57.6%	0.046%
2/17/2025	D. E. Shaw & Co. Inc.	716,253	$8.86M	0.0%	+71.2%	0.470%
2/17/2025	Driehaus Capital Management LLC	6,712,449	$83.03M	0.7%	+14.6%	4.401%
2/17/2025	Corton Capital Inc.	17,051	$0.21M	0.1%	-58.3%	0.011%
2/17/2025	Crestline Management LP	158,336	$1.96M	0.1%	+17.1%	0.104%
2/17/2025	Bamco Inc. NY	85,000	$1.05M	0.0%	N/A	0.056%
2/17/2025	Bank of America Corp DE	435,896	$5.39M	0.0%	+58.5%	0.286%
2/17/2025	BNP Paribas Financial Markets	142,842	$1.77M	0.0%	+241.5%	0.094%
2/17/2025	Ameriprise Financial Inc.	10,414	$0.13M	0.0%	N/A	0.007%
2/17/2025	Algert Global LLC	42,564	$0.53M	0.0%	N/A	0.028%
2/17/2025	683 Capital Management LLC	3,785,000	$46.82M	2.9%	-9.9%	2.482%
2/14/2025	PDT Partners LLC	69,220	$0.86M	0.1%	-7.7%	0.045%
2/14/2025	Emerald Mutual Fund Advisers Trust	1,931,034	$23.89M	1.5%	-9.1%	1.266%
2/14/2025	Northern Trust Corp	961,751	$11.90M	0.0%	+20.3%	0.631%
2/14/2025	The Manufacturers Life Insurance Company	207,687	$2.57M	0.0%	+23.5%	0.136%
2/14/2025	Quarry LP	5,000	$62K	0.0%	N/A	0.003%
2/14/2025	Aquatic Capital Management LLC	82,018	$1.02M	0.0%	N/A	0.054%
2/14/2025	Virtus ETF Advisers LLC	5,133	$63K	0.0%	-63.9%	0.003%
2/14/2025	Nebula Research & Development LLC	27,137	$0.34M	0.0%	N/A	0.018%
2/14/2025	Voya Investment Management LLC	77,160	$0.95M	0.0%	+198.2%	0.051%
2/14/2025	Adage Capital Partners GP L.L.C.	9,622,104	$119.03M	0.2%	-0.8%	6.309%
2/14/2025	Price T Rowe Associates Inc. MD	5,098,866	$63.07M	0.0%	+63.1%	3.343%
2/14/2025	Dark Forest Capital Management LP	24,151	$0.30M	0.0%	N/A	0.016%
2/14/2025	Silverarc Capital Management LLC	608,897	$7.53M	1.6%	-3.0%	0.399%
2/14/2025	Hsbc Holdings PLC	10,721	$0.13M	0.0%	-25.0%	0.007%
2/14/2025	M28 Capital Management LP	5,664,548	$70.07M	68.8%	-8.1%	3.714%
2/14/2025	MetLife Investment Management LLC	55,941	$0.69M	0.0%	+28.3%	0.037%
2/13/2025	Marshall Wace LLP	183,875	$2.28M	0.0%	+43.0%	0.121%
2/13/2025	EAM Investors LLC	214,717	$2.66M	0.4%	N/A	0.141%
2/13/2025	Affinity Asset Advisors LLC	1,500,000	$18.56M	2.5%	+7.1%	0.983%
2/13/2025	Jump Financial LLC	123,707	$1.53M	0.0%	N/A	0.081%
2/13/2025	Walleye Capital LLC	526,698	$6.52M	0.0%	-12.6%	0.345%
2/13/2025	Barclays PLC	195,553	$2.42M	0.0%	+22.8%	0.128%
2/13/2025	Summit Investment Advisors Inc.	9,642	$0.12M	0.1%	+31.5%	0.006%
2/13/2025	F M Investments LLC	226,034	$2.80M	0.1%	N/A	0.148%
2/13/2025	Raymond James Financial Inc.	12,715	$0.16M	0.0%	N/A	0.008%
2/13/2025	Martingale Asset Management L P	10,300	$0.13M	0.0%	-90.7%	0.007%
2/13/2025	Renaissance Technologies LLC	41,520	$0.51M	0.0%	-60.3%	0.027%
2/13/2025	Legal & General Group Plc	118,654	$1.47M	0.0%	+25.7%	0.078%
2/13/2025	Invesco Ltd.	40,010	$0.50M	0.0%	+12.2%	0.026%
2/13/2025	ADAR1 Capital Management LLC	21,700	$0.27M	0.1%	N/A	0.014%
2/13/2025	Westwood Wealth Management	10,000	$0.12M	0.0%	N/A	0.007%
2/13/2025	Federated Hermes Inc.	68,020	$0.84M	0.0%	N/A	0.045%
2/13/2025	Russell Investments Group Ltd.	44,648	$0.55M	0.0%	+3,471.8%	0.029%
2/13/2025	Envestnet Asset Management Inc.	32,331	$0.40M	0.0%	+64.9%	0.021%
2/13/2025	Wells Fargo & Company MN	49,856	$0.62M	0.0%	+84.8%	0.033%
2/12/2025	Cinctive Capital Management LP	191,963	$2.38M	0.1%	-46.1%	0.126%
2/12/2025	Trexquant Investment LP	439,352	$5.44M	0.1%	+52.1%	0.288%
2/12/2025	Geode Capital Management LLC	2,470,751	$30.57M	0.0%	+8.9%	1.620%
2/12/2025	Franklin Resources Inc.	42,526	$0.53M	0.0%	-54.3%	0.028%
2/12/2025	Alliancebernstein L.P.	90,590	$1.12M	0.0%	+56.0%	0.059%
2/12/2025	Wellington Management Group LLP	311,303	$3.85M	0.0%	-1.3%	0.204%
2/12/2025	Pictet Asset Management Holding SA	15,579	$0.19M	0.0%	+36.0%	0.010%
2/12/2025	Norges Bank	100,000	$1.24M	0.0%	N/A	0.066%
2/12/2025	Loomis Sayles & Co. L P	1,660,866	$20.55M	2.2%	N/A	1.089%
2/12/2025	Artisan Partners Limited Partnership	1,906,790	$23.59M	0.0%	-2.7%	1.250%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	17,109	$0.23M	0.0%	-58.9%	0.011%
2/11/2025	Corebridge Financial Inc.	45,824	$0.57M	0.0%	+10.7%	0.030%
2/11/2025	Emerald Advisers LLC	3,162,369	$39.12M	1.5%	+9.7%	2.073%
2/11/2025	Vanguard Group Inc.	3,182,512	$39.37M	0.0%	+10.2%	2.087%
2/11/2025	KLP Kapitalforvaltning AS	20,800	$0.26M	0.0%	N/A	0.014%
2/11/2025	Sei Investments Co.	77,610	$0.96M	0.0%	+13.3%	0.051%
2/11/2025	Virtu Financial LLC	20,819	$0.26M	0.0%	N/A	0.014%
2/11/2025	Quantbot Technologies LP	68,927	$0.85M	0.0%	N/A	0.045%
2/11/2025	Teacher Retirement System of Texas	31,473	$0.39M	0.0%	+57.6%	0.021%
2/11/2025	Privium Fund Management B.V.	88,000	$1.09M	0.2%	+80.2%	0.058%
2/11/2025	Platinum Investment Management Ltd.	311,992	$3.86M	0.2%	-32.4%	0.205%
2/10/2025	Primecap Management Co. CA	2,519,520	$31.17M	0.0%	-2.4%	1.652%
2/10/2025	Swiss National Bank	208,800	$2.58M	0.0%	+33.4%	0.137%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	387,871	$4.80M	0.0%	+19.3%	0.254%
2/6/2025	Raymond James Financial Inc.	12,715	$0.16M	0.0%	N/A	0.008%
2/6/2025	Arizona State Retirement System	30,769	$0.38M	0.0%	+34.2%	0.020%
2/6/2025	Aigen Investment Management LP	21,854	$0.27M	0.0%	N/A	0.014%
2/6/2025	Victory Capital Management Inc.	14,546	$0.18M	0.0%	+16.6%	0.010%
2/6/2025	Charles Schwab Investment Management Inc.	914,469	$11.31M	0.0%	+8.3%	0.600%
2/5/2025	US Bancorp DE	7,530	$93K	0.0%	-58.3%	0.005%

Data available starting January 2016

See Full Table

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

Today's Range

Now: $8.08

$7.92

$8.40

50 Day Range

MA: $10.73

$8.62

$12.24

52 Week Range

Now: $8.08

$4.25

$16.74

Volume

2,522,557 shs

Average Volume

1,131,374 shs

Market Capitalization

$1.24 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Wave Life Sciences?: Wave Life Sciences' top insider shareholders include:
Ra Capital Management, LP (Director)
Plc Gsk (Major Shareholder)
Paul Bolno (CEO)
Kyle Moran (CFO)
Christian O Henry (Director)
Chris Francis (Insider)
Learn More about top insider investors at Wave Life Sciences.
Who are the major institutional investors of Wave Life Sciences?: Wave Life Sciences' top institutional shareholders include:
Adage Capital Partners GP L.L.C. — 6.31%
Driehaus Capital Management LLC — 4.40%
M28 Capital Management LP — 3.71%
Price T Rowe Associates Inc. MD — 3.34%
683 Capital Management LLC — 2.48%
Vanguard Group Inc. — 2.09%
Learn More about top institutional investors of Wave Life Sciences stock.
Which major investors are selling Wave Life Sciences stock?: In the previous quarter, WVE stock was sold by these institutional investors:
Maven Securities LTD
M28 Capital Management LP
683 Capital Management LLC
Emerald Mutual Fund Advisers Trust
Cinctive Capital Management LP
Platinum Investment Management Ltd.
Martingale Asset Management L P
Adage Capital Partners GP L.L.C.
During the previous year, company insiders that have sold Wave Life Sciences company stock include:
Ra Capital Management, LP (Director)
Plc Gsk (Major Shareholder)
Paul Bolno (CEO)
Kyle Moran (CFO)
Learn More investors selling Wave Life Sciences stock.
Which major investors are buying Wave Life Sciences stock?: Within the previous quarter, WVE stock was bought by institutional investors including:
Price T Rowe Associates Inc. MD
Loomis Sayles & Co. L P
Polar Capital Holdings Plc
MPM Bioimpact LLC
Driehaus Capital Management LLC
Voloridge Investment Management LLC
Stempoint Capital LP
Universal Beteiligungs und Servicegesellschaft mbH
Within the previous year, these company insiders have bought Wave Life Sciences stock:
Ra Capital Management, LP (Director)
Plc Gsk (Major Shareholder)
Learn More investors buying Wave Life Sciences stock.